Loss of angulin-1/LSR promotes vasculogenic mimicry and epithelial-mesenchymal transition in breast cancer

J Biol Chem. 2025 Oct;301(10):110635. doi: 10.1016/j.jbc.2025.110635. Epub 2025 Aug 27.

Abstract

Vasculogenic mimicry (VM) is a process by which tumor cells form vessel-like network to secure oxygen and nutrients essential for tumor growth. Intercellular junctions, including tight junctions, may play a critical role in this process, important for VM. Here, we investigated the role of angulin-1/LSR (Ang-1), a key component of tricellular tight junctions, in VM regulation. We performed VM assay using Ang-1 KO breast cancer cells. Compared with control cells, Ang-1/KO cells exhibited significantly enhanced VM formation, accompanied by increasing epithelial-mesenchymal transition features. In a xenograft model, tumors derived from Ang-1/KO cells showed increased mass and elevated VM ratios. Re-expression of Ang-1 isoforms 3, 4, or 6-2 in Ang-1/KO cells suppressed VM formation, whereas isoforms 1, 2, and 6 had no effect. RT-PCR analysis of breast cancer patient tissues confirmed the lower expression of Ang-1 isoform 6-2, which suppresses VM. These findings identify Ang-1 as a novel regulator of VM and suggest that specific isoforms, particularly isoform 6-2, may serve as isoform-specific diagnostic markers or therapeutic targets in breast cancer.

Keywords: EMT; angulin-1/LSR; biomarker; breast cancer; cell junction; tight junction; vasculogenic mimicry.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Breast Neoplasms* / blood supply
  • Breast Neoplasms* / genetics
  • Breast Neoplasms* / metabolism
  • Breast Neoplasms* / pathology
  • Cell Line, Tumor
  • Epithelial-Mesenchymal Transition*
  • Female
  • Humans
  • Mice
  • Neovascularization, Pathologic* / genetics
  • Neovascularization, Pathologic* / metabolism
  • Neovascularization, Pathologic* / pathology